N🟁N

NVTL, HJO, IDIX, CRTX, OBAS, WCRX Are Seasonally Ripe To Go Down In the Next Five Weeks

October 20, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of NOVATEL WIRELESS INC (NASDAQ:NVTL), MS Structured Asset Corp. SATURNS Aon Capital Security Backed Series 20052 6.8 (NYSE:HJO), IDENIX PHARMACEUTICALS INC (NASDAQ:IDIX), CORNERSTONE THERAPEUTICS INC (NASDAQ:CRTX), Optibase Ltd. - Ordinary Shares (NASDAQ:OBAS), WARNER CHILCOTT PLC-CLASS A (NASDAQ:WCRX) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

     Symbol     Company                             Expected Return     Odds                    By The Following Date
     NVTL       NOVATEL WIRELESS INC                -18.36%             90.00% (9 of 10)        Tuesday, November 29th 2011
     HJO        MS Structured Asset Corp. SATURNS Aon Capital Security Backed Series 20052 6.8     -5.08%              66.67% (4 of 6)         Tuesday, November 15th 2011
     IDIX       IDENIX PHARMACEUTICALS INC          -7.85%              100.00% (7 of 7)        Thursday, November 3rd 2011
     CRTX       CORNERSTONE THERAPEUTICS INC        -3.71%              100.00% (7 of 7)        Tuesday, October 25th 2011
     OBAS       Optibase Ltd. - Ordinary Shares     -6.75%              90.91% (10 of 11)       Wednesday, October 26th 2011
     WCRX       WARNER CHILCOTT PLC-CLASS A         -5.38%              100.00% (5 of 5)        Wednesday, November 9th 2011

NOVATEL WIRELESS INC (NASDAQ:NVTL) - Novatel Wireless, Inc. provides wireless broadband access solutions for the mobile communications market worldwide. The company primarily offers third generation (3G) products. It provides intelligent mobile hotspots, which offer WLAN and WWAN wireless connectivity to up to five users simultaneously from a range of devices, including notebook computers, music players, and digital cameras, as well as a platform to host software applications under the MiFi brand name; and embedded PCI express mini card modems that are designed for integration into multiple laptop platforms and other wireless devices under the Expedite brand name. The company also offers USB modems, which provide wireless connectivity to desktop and other fixed computing devices, as well as to laptop PCs and other portable computing devices; and Merlin wireless PC card and expresscard modems that offer mobile subscribers with high-speed wireless access to data, including corporate, public, and personal information through Internet and enterprise networks. In addition, it provides MobiLink Mobile Communications software suite, an application that enables a user to access to connectivity features, such as SMS, multimedia messaging, and virtual private networking. The company serves wireless operators, laptop PC and other original equipment manufacturers, distributors, and various companies in other vertical markets. It has strategic relationships with Alcatel-Lucent, Dell, QUALCOMM, Sprint PCS, Verizon Wireless, Virgin Mobile, Vodafone, and Telefonica. The company was founded in 1996 and is based in San Diego, California.

MS Structured Asset Corp. SATURNS Aon Capital Security Backed Series 20052 6.8 (NYSE:HJO) - MS Structured Asset Corp. SATURNS Aon Capital Security Backed Series 20052 6.8

IDENIX PHARMACEUTICALS INC (NASDAQ:IDIX) - Idenix Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of drugs for the treatment of human viral and other infectious diseases in the United States and Europe. The company primarily focuses its research and development on the treatment for hepatitis C virus. The company develops nucleoside/nucleotide polymerase inhibitors, including IDX184, a liver-targeted nucleotide prodrug candidate, which is in phase IIa clinical trial; and IDX102 that completed late-stage preclinical development. It also develops IDX375, a novel palm-binding polymerase inhibitor that is in phase I program; IDX320, a protease inhibitor candidate, which is in phase I healthy volunteer clinical study; and NS5A inhibitors. In addition, the company licensed its telbivudine (Tyzeka/Sebivo), a drug for the treatment of hepatitis B virus, to Novartis Pharma AG; and GSK2248761, a drug candidate from the class of compounds known as non-nucleoside reverse transcriptase inhibitors (NNRTIs), for the treatment of human immunodeficiency virus type 1 and acquired immune deficiency syndrome to GlaxoSmithKline. The company was founded in 1998 and is headquartered in Cambridge, Massachusetts.

CORNERSTONE THERAPEUTICS INC (NASDAQ:CRTX) - Cornerstone Therapeutics Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of branded and generic pharmaceuticals for the respiratory and related markets primarily in the United States. It offers a line of products, including CUROSURF, an natural lung surfactant, for the treatment of respiratory distress syndrome in premature infants; FACTIVE, a fluoroquinolone with an activity against certain microorganisms implicated in respiratory infections, such as multi-drug resistant strains of Streptococcus pneumoniae; SPECTRACEF, a cephalosporin for the treatment of respiratory and skin infections; and ZYFLO CR, a leukotriene synthesis inhibitor, for prophylaxis and chronic treatment of asthma. The company also markets ALLERX dose pack products that are prescribed for the treatment of symptoms of allergic rhinitis; and HYOMAX family of products, which may be prescribed for functional intestinal disorders to reduce symptoms such as those seen in mild dysenteries, diverticulitis and irritable bowel syndrome. In addition, it develops cough/cold product candidates comprising CRTX 067, CRTX 069, CRTX 072, and CRTX 074; allergy product candidates consisting of CRTX 058 and CRTX 070; CRTX 073, an anti-asthma product candidate; and anti-infective product candidates, including CRTX 062 and CRTX 068. The company is headquartered in Cary, North Carolina. As of December 31, 2009, Cornerstone Therapeutics Inc. operates as a subsidiary of Chiesi Farmaceutici S.p.A.

Optibase Ltd. - Ordinary Shares (NASDAQ:OBAS) - Optibase Ltd., incorporated in 1990, provides high quality equipment for a range of professional video applications in the Broadband Internet Protocol Television (IPTV), broadcast, government, enterprise and post-production markets. During the year ended December 31, 2005, Optibase operated three product lines: Video Technologies (previously called Building Blocks), IPTV (previously called Broadband Television) and Digital Non-Linear Editing. The Company's products from all three product lines are generally manufactured by the same subcontractors by the use of similar raw materials purchased from the same suppliers. Optibase markets its products through a combined sales and marketing team and sell them by way of direct sales and through independent distributors, system integrators and resellers. In September 2005, the Company entered into an agreement for the sale of its Digital Non-Linear Editing operation to Artel Software Corp. (commonly known as Boris FX).

Video Technologies

The Video Technologies products target the broadcast, government, enterprise and post-production markets. In the enterprise markets, Optibase's encoding and streaming products enable applications, such as corporate training, videoconferencing, television to the desktop and corporate video messages distributed over the corporate network. In the governmental markets, the products enable the logging and streaming of legal and legislative proceedings, surveillance, military and police monitoring, and simulated training sessions for later retrieval and debrief. In the broadcast markets, the products enable the preparation of video content for video on demand or Broadcast servers, the playout of video from servers, ad-insertion into channel feeds, and the monitoring and archiving of channels for compliance checks as required by the regulator in some countries.

Optibase sells the Video Technologies products directly to original equipment manufacturers and to video system integrators and also through a worldwide network of distributors, resellers and value added resellers. The Video Technologies products consist of Peripheral Component Interconnect (PCI) platforms for encoding, decoding and interfacing with Digital Video Broadcast (DVB) networks, and Media Gateways.

The Company develops and markets platforms that can be inserted into a host computer (personal computer or Macintosh), for encoding video into compressed digital formats and decoding compressed digital formats into playable video. These platforms connect to the host computer using the PCI bus. In addition, the products enable the transmission of such compressed digital formats over DVB networks. The PCI platforms are the basis for other products. They are also sold to system integrators who use them to build their own professional video applications. They are provided with documented software Developer Kits (SDKs) to facilitate the development by its customers. Based on these encoder and decoder platforms, Optibase also develops and markets content creation software applications, which run on the personal computer and the Mackintosh computer respectively. In addition to the PCI platforms, the Company also develops and makes integrated devices for encoding and streaming, which it has called Media Gateways. These devices do not require installation of hardware and are remotely managed by either a Web interface or an SNMP management application. They do not use the PCI platforms for encoding or decoding though they are based on similar technology.

In this segment, the Company competes with VBrick Systems Inc., Amnis Systems, Verint Systems, Inc., Vela Research Inc., Dektec, VideoPropulsion, CMI, Stradis, Inc., Canopus, Matrox, Digital Rapids, Ligos, Winnov, Inc. and Viewcast, Inc.

Internet Protocol Television (IPTV)

The primary market of the IPTV product line is the IPTV market, which mainly consists of telephone operators and Internet service providers worldwide who are offering broadband and telephone services. These companies are exploring ways to leverage their existing

WARNER CHILCOTT PLC-CLASS A (NASDAQ:WCRX) - Warner Chilcott plc, a specialty pharmaceutical company, focuses on the development, manufacture, and promotion of branded pharmaceutical products in womens healthcare, gastroenterology, dermatology, and urology segments in North America and western Europe markets. It primarily offers ACTONEL for the prevention and treatment of postmenopausal osteoporosis; ATELVIA for the treatment of postmenopausal osteoporosis; LOESTRIN 24 FE and LO LOESTRIN FE, which are oral contraceptives for the prevention of pregnancy; ESTRACE cream, a vaginal cream for the treatment of vaginal and vulvar atrophy; ASACOL for the treatment of ulcerative colitis for orally administered 5-aminosalicylic acid products; ASACOL HD for the treatment of moderately active ulcerative colitis; DORYX, a tetracycline-class oral antibiotic for the treatment of severe acne; and ENABLEX for the treatment of symptoms of overactive bladder. The company markets its products and services through wholesale pharmaceutical distributors, and retail drug store chains. It has a strategic collaboration agreement with Sanofi-Aventis U.S. LLC. The company was founded in 1968 and is headquartered in Dublin, Ireland.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641